GlaxoSmithKline's Dr.Ira Gupta and Gilead Sciences' Dr. Shanthi Ganeshan break down breakthrough designations, winning them, and bouncing back from rejection.
Geoff MacKay, president and CEO of AVROBIO, talks about the scale-up obstacles facing the cell and gene therapy space and how AVRO is working to tackle them.
Dr. Gene Lee, vice president of technical development at AltruBio, discusses getting the developability question right and why it’s important to understand your end game as early as discovery.
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Cytiva brings speed, efficiency, and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients. Visit their new Emerging Biotech site for more resources for early-stage biopharmas.
This website uses cookies to ensure you get the best experience on our website. Learn more